← All 3m CO filings

3m CO 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NYSE
MMM
3m CO
10-K: 3M posts modest growth, exits PFAS output
3M delivered slight sales growth in 2025, lifted margins on an adjusted basis, completed its PFAS manufacturing exit, and advanced major legal settlements while boosting dividends and buybacks.
NYSE
MMM
3m CO
10-K: 3M Reports Full Year 2024 Results, Navigates Litigation and Completes Solventum Spin-Off
3M's 2024 full-year report reflects a mixed performance amid significant litigation settlements, restructuring charges, and the spin-off of its healthcare business, Solventum.
NYSE
MMM
3m CO
10-K: 3M Annual Incentive Plan and 10-K Filing Reveal Executive Compensation and Business Strategy
3M's annual incentive plan and 10-K filing detail executive compensation structures, business segment performance, and strategic initiatives, including a planned healthcare spin-off and PFAS manufacturing exit.